PLAYSAFE
LIVE

Serial Number

98404511

Owner

Randox Laboratories Limited

Attorney

Douglas N. Masters

Filing Date

Feb 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PLAYSAFE Trademark

Serial Number: 98404511

PLAYSAFE is a trademark filed by Randox Laboratories Limited on February 13, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Randox Laboratories Limited (18 trademarks)

Ardmore
Co. Antrim , GB

Entity Type: 99

Trademark Details

Filing Date

February 13, 2024

Registration Date

Not Registered

Published for Opposition

October 14, 2025

Goods & Services

Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; Diagnostic preparations for scientific purposes; Chemical reagents, other than for medical or veterinary purposes; Enzymes and proteins for industrial use; Diagnostic preparations for analysis of food products and water for scientific and research purposes; Clinical diagnostics preparations for scientific use; Diagnostic scanning agents for scientific use; Diagnostic testing materials for scientific use; Replacement parts and fittings for all the aforesaid goods

Medical services; hygienic and beauty care for human beings; consulting services relating to health care; health advice and information services; medical care services; health clinic services; healthcare services; medical consultations and lifestyle consultations, namely, professional consultations to individuals to assess their personal health and wellbeing; medical health assessment services; health screening services; diagnostic health screening services; preparation of reports relating to health care matters; professional consultancy relating to health; medical testing; medical diagnostic testing; nursing services; nursing care services; medical health and fitness assessment services; medical advisory and consultancy services relating to immunology; advisory and consultancy services relating to nutrition; cholesterol testing; genetic testing for medical purposes; hearing tests; services for the testing of blood; services for the testing of sera; services for the testing of urine; services for testing of bone functions; services for testing of major body organs; services for the testing of fertility hormone levels; health screening for pregnant women; pregnancy testing; prenatal care services; postnatal care services; services for the testing of diabetes; services for the testing of thyroid function; services for testing iron levels; medical assistance; medical clinics; information, consultancy and advice relating to any of the aforesaid services

Pharmaceutical, veterinary and sanitary preparations and substances for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseases, coronary heart disease, brain diseases, cancer, diabetes, kidney diseases, renal diseases, anemia, dementia, nervous system dysfunctions, diseases of the central nervous system, autoimmune diseases, allergy, vascular diseases, infertility, menopause, early or delayed puberty, reproductive or non-reproductive disorders, gastrointestinal disorders, digestive diseases and conditions, metabolic diseases, hypercalcemia, thyroid diseases, bone disorders, respiratory diseases, infectious diseases, sexually transmitted diseases, and urinary tract infections, testing high or low levels of testosterone, testing for calcium absorption, testing of blood levels, antimicrobial testing, and screening for drug use; blood sera and blood anti-sera, for medical and veterinary use; diagnostic preparations for medical purposes; diagnostic preparations and substances for medical and veterinary purposes; kits for medical purposes comprised of pharmaceutical preparations for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseases, coronary heart disease, brain diseases, cancer, diabetes, kidney diseases, renal diseases, anemia, dementia, nervous system dysfunctions, diseases of the central nervous system, autoimmune diseases, allergy, vascular diseases, infertility, menopause, early or delayed puberty, reproductive or non-reproductive disorders, gastrointestinal disorders, digestive diseases and conditions, metabolic diseases, hypercalcemia, thyroid diseases, bone disorders, respiratory diseases, infectious diseases, sexually transmitted diseases, and urinary tract infections, testing high or low levels of testosterone, testing for calcium absorption, testing of blood levels, antimicrobial testing, and screening for drug use; clinical diagnostics preparations, for medical or veterinary use; clinical diagnostic reagents for in vitro and vivo use; diagnostic scanning agents for in vivo use; diagnostic testing materials for medical and veterinary use; clinical medical reagents; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes; replacement parts and fittings for all the aforesaid goods

Medical diagnostic kits, consisting of containers, analyzers and disposable cartridges, namely, apparatus for processing, testing and analyzing of bodily fluids; medical diagnostic kits, consisting of containers, analyzers and disposable cartridges, namely, apparatus for testing or detecting sexually transmitted infections (STI); clinical laboratory analytical instruments for medical or veterinary use, namely, for the analysis of bodily fluids, for use in in vitro diagnostic testing procedures, and for use with clinical chemistry analyzers, blood testing apparatus, and diagnostic saliva vials

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 9, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 19, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2025 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 7, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 6, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 5, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 5, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 6, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 6, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2024 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 12, 2024 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2024 NWOS
NEW APPLICATION ENTERED
Feb 13, 2024 NWAP